- Non-invasive, safe, convenient, and patient-friendly.
- No need for hospitalization/visit to an advanced healthcare facility.
- No inconveniences, and no procedural risks.
- No exposure to radiation.
- Can improve the early detection of cancers for which standard screening is available.
- Can help early detection of cancers for which no screening is offered.
Effect of Our Proprietary CEM on Benign Cells, PBMCs and Cancer Cells
(CEM = CTC Enrichment Medium, PBMCs = Peripheral Blood Mononuclear Cells)
Our novel process for functional enrichment of CTCs is based on apoptosis reluctance, a hallmark of cancer cells. The process selectively eliminates all non-malignant cells (which have an intact apoptosis mechanism) while malignant cells (which evade apoptosis) survive. Circulating tumor cells and their clusters are ubiquitous in the blood of individuals with cancer and are uncommon in patients with benign conditions or otherwise healthy individuals.
A Revolutionary Blood Test To Detect Caner Early, So That It Could Be Cured.
A Simple Blood Test for Cancer Diagnosis. It Could Save Your Life.
We Can Help Physicians Make More Informed Treatment Decisions.
A Powerful Test For Better Management And Monitoring of Cancer Treatments.
Guildford, Surrey, GU2 7YD,